Skip to main content

Doogan Declan

In the past year, 1 open-market purchase filing worth $101.8K and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$101.8K
1 filing
Sold
–
0 filings
Net
+$101.8K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Doogan Declan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TENX Tenax Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 17, 2026 (view filing)9:30 PM ETSep 161 dayDoogan DeclanDirectorPPurchase+53.0K$1.92+$101.8K+2,330.7%55.3K after

Biohaven Pharmaceutical Holding Co Ltd.

Director6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 11, 2022 (view filing)Jun 15-16, 2020606 daysDoogan DeclanDirectorSSale−18.0K$68.48−$1.23M−2.6%676.0K afterAmended2 lots
Feb 11, 2022 (view filing)Jun 15-16, 2020606 daysDoogan DeclanDirectorSSale−23.3K$68.50−$1.60M−6.7%323.9K afterAmended2 lots
Feb 11, 2022 (view filing)Jun 11-12, 2020610 daysDoogan DeclanDirectorSSale−24.3K$65.01−$1.58M−3.0%792.7K afterAmended2 lots
Feb 11, 2022 (view filing)Jun 11-12, 2020610 daysDoogan DeclanDirectorSSale−26.7K$65.36−$1.74M−7.1%347.2K afterAmended2 lots
Dec 1, 2021 (view filing)Nov 292 daysDoogan DeclanDirectorSSale−24.5K$112.80−$2.77M−2.7%870.6K after2 lots
Nov 17, 2021 (view filing)Nov 161 dayDoogan DeclanDirectorSSale−37.7K$116.65−$4.40M−4.0%895.2K after3 lots